GLYCOZYM ApS: Financial statements 2023
CVR: 25046684
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
GLYCOZYM ApS (CVR 25046684) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 90,517 and a net result of DKK -6,257 compared with DKK 7,230 the year before. Equity in the 2023 report amounted to DKK 1,786,822. The solvency ratio was 75.1%.
- Gross Profit
- DKK 90,517
- Profit/Loss
- DKK -6,257
- Equity
- DKK 1,786,822
- Total Assets
- DKK 2,380,798
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 91K | -6K | 1.8M | 0 |
| 2022 | - | 0 | 7K | 1.8M | 0 |
| 2021 | - | 0 | 295K | 1.8M | 0 |
| 2020 | - | -20K | -37K | 1.5M | 0 |
| 2019 | - | 82K | -23K | 1.5M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GLYCOZYM ApS has published its annual report for 2022. Gross profit came to DKK 0, and the net result was DKK 7,230.
About GLYCOZYM ApS
GLYCOZYM ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1999. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ApS KBUS 8 NR. 5112. The management consists of Henrik Clausen. The company is owned by Ulla Marie Clausen, Henrik Clausen and Eric Paul Bennett. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 93,645 and a net result of DKK -10,993 compared with DKK -232 the year before. Equity in the 2025 report amounted to DKK 1,775,597.
